KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Cash from Financing Activities: 2009-2025

Historic Cash from Financing Activities for Astrana Health (ASTH) over the last 17 years, with Q3 2025 value amounting to $648.5 million.

  • Astrana Health's Cash from Financing Activities rose 2042887.15% to $648.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $551.5 million, marking a year-over-year increase of 11479.37%. This contributed to the annual value of $135.1 million for FY2024, which is 385048.23% up from last year.
  • Astrana Health's Cash from Financing Activities amounted to $648.5 million in Q3 2025, which was up 2042887.15% from -$8.6 million recorded in Q2 2025.
  • Astrana Health's Cash from Financing Activities' 5-year high stood at $648.5 million during Q3 2025, with a 5-year trough of -$44.2 million in Q1 2025.
  • For the 5-year period, Astrana Health's Cash from Financing Activities averaged around $35.1 million, with its median value being -$963000.0 (2023).
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first plummeted by 143439.85% in 2023, then surged by 2042887.15% in 2025.
  • Quarter analysis of 5 years shows Astrana Health's Cash from Financing Activities stood at $1.4 million in 2021, then skyrocketed by 309.13% to $5.9 million in 2022, then surged by 104.28% to $12.0 million in 2023, then plummeted by 227.3% to -$15.3 million in 2024, then surged by 4347.66% to $648.5 million in 2025.
  • Its Cash from Financing Activities stands at $648.5 million for Q3 2025, versus -$8.6 million for Q2 2025 and -$44.2 million for Q1 2025.